FLEXIM Instruments UK Ltd team provide the NHS with critically important Oxygen Metering to hospital Covid 19 wards
Date published:
April 30, 2020
FLEXIM clamp-on gas meters are now on critical oxygen supply lines in UK hospitals.The Easy retrofit clamp-on introduces no leak paths and provides instantaneous demand information for critically important O2 delivery to Coronavirus (COVID-19) wards.“FLEXIM Instruments UK Ltd and our sales partners JWF in Scotland, are proud to be playing our small part in supporting the NHS at this challenging time. We also thank our colleagues in the FLEXIM GmbH factory for prioritising production of these important meters.” Andy Hammond, Managing Director, General Manager, Flexim InstrumentsRead more information on the Clamp-On Oxygen Monitoring in hospitals Here
More from the water sector
Find out how the UK water sector is informing, innovating, and influencing change
Future Water Awards 2026 – Nominations now open
Celebrate excellence in the UK water sector by nominating outstanding individuals and organisations for the 2026 Future Water Awards, recognising emerging talent, people, and above-and-beyond contributions.
Turning the tide: How Gen Z could reshape water’s reputation
For much of the past decade, the water sector has been discussed in stark, national terms — collapsing trust, environmental failure and a licence to operate under sustained pressure. Cavenish’s latest polling shows just how entrenched those views have become. It also reveals something more important: the future narrative of water has not yet been written.
Cavendish Consulting latest polling shows positivity yet demand from Gen Z when asked about water companies
Open and shared data in the business retail market is moving from idea to test, creating potential opportunities for FWA members
Cross 8 presented a benefits case on Open and Shared Data to the Strategic Panel that oversees the business retail market. The Panel has approved moving to a proof of value phase.
Cross 8 presented an Open & Shared Data benefits case to the Strategic Panel, which approved progressing to a proof of value phase.